Exhibit 107
Calculation of Filing Fee Tables
S-1
(Form Type)
Navidea Biopharmaceuticals, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| | Security Type | Security Class Title | Fee Calculation Rate | Amount Registered | | Proposed Maximum Offering Price Per Unit | | Maximum Aggregate Offering Price | Fee Rate | | Amount of Registration Fee |
Fees to be paid | Other | Subscription Rights to purchase Common Stock, par value $0.001 per share (1),(2) | 457(g) | N/A | $ | — | $ | — | — | $ | — |
| | Equity | Common Stock, par value $0.001 per share, issuable upon exercise of Subscription Rights (1) | 457(o) | | $ | | $ | 35,000,000 (3) | 0.0000927 | $ | 3,244.50 |
Fees previously paid | | | | | | | | | | | |
Total Offering Amounts | | | | | | | $ | 35,000,000 | | $ | 3,244.50 |
Fees Previously Paid | | | | | | | | | | $ | 0.00 |
Net Fees Due | | | | | | | | | | $ | 3,244.50 |
(1) | This Registration Statement relates to: (a) non-transferable Subscription Rights to purchase Common Stock of the Registrant, which Subscription Rights are to be issued to holders of the Registrant's Common Stock on a pro rata basis without consideration, and (b) the shares of the Registrant's Common Stock issuable upon the exercise of such non-transferable Subscription Rights pursuant to the Rights Offering. |
(2) | The Subscription Rights are being issued without consideration. No separate registration fee is payable with respect to the Subscription Rights being offered hereby since the Subscription Rights are being registered in the same Registration Statement as the Common Stock underlying the Subscription Rights. |
(3) | Represents the estimated gross proceeds from the assumed exercise of all Subscription Rights. |
